PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects Prostate Cancer," (1) demonstrating clinical validation ...

Researchers suggest their approach has the potential to transform early disease detection and health monitoring across diverse clinical settings.

The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...

Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans. SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, ...

A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results ...

UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting ...

A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...

Pancreatic cancer rarely announces itself early. It often grows in deep tissue, causes vague symptoms, and reaches medical ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...